Search filters

List of works by Lionel Spielmann

Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes

scientific article published on 24 May 2019

Artificial intelligence should always be guided by human intelligence. Response to 'Augmented vs. artificial intelligence for stratification of patients with myositis' by Mahler et al

scientific article published on 30 July 2019

On how to not misuse hierarchical clustering on principal components to define clinically meaningful patient subgroups. Response to: 'On using machine learning algorithms to define clinical meaningful patient subgroups' by Pinal-Fernandez and Mammen

scientific article published on 24 July 2019

Population-based prevalence of Eosinophilic (Shulman's) Fasciitis: a capture-recapture study.

scientific article published on 11 March 2018

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept

scientific article published on 30 April 2020

Response to: 'Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies' by Yang et al

scientific article published on 25 March 2020

Response to: 'Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients' by Ogawa-Momohara et al

scientific article published on 04 December 2019

Rheumatic diseases and COVID-19: a cohort of 17 patients under DMARDs. Response to: 'Comment on: Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic ar

scientific article published on 18 August 2020

The heart of anti-Ku related disease: extensive review and meta-analysis. Response to: 'Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis' by Campochiaro et al

scientific article published on 20 September 2019

Welcome to EULAR's guidelines for the use of big data techniques in rheumatic and musculoskeletal diseases. Response to: 'On using machine learning algorithms to define clinically meaningful patient subgroups' by Knevel and Huizinga

scientific article published on 17 August 2019